All In Biotech

Drug Trial Radar · NCT04816604

Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)

Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

74

Actual

Start

Apr 5, 2021

Primary completion

Sep 9, 2026

Study completion Sep 9, 2026

Sponsor

Lead sponsor
Gossamer Bio USA, Inc.Industry
Sponsor type
Industry
First posted
Mar 25, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This open-label extension study will evaluate the long-term effects of GB002 (seralutinib) in subjects who previously participated in a GB002 PAH study.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • GB002 (seralutinib)Drug

    Capsule containing GB002 (seralutinib)

  • Generic Dry Powder InhalerDevice

    Generic dry powder inhaler for GB002 (seralutinib) delivery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment Emergent Adverse EventsTime frame: From first dose of study drug up to 80 months or availability of commercial product

Locations

28 sites in 7 countries. Site status is shown where the registry gives one.

  • University of California, Davis Medical Center

    Sacramento, California

  • Medical Corporation

    Santa Barbara, California

  • Mayo Clinic

    Jacksonville, Florida

  • Cleveland Clinic Florida

    Weston, Florida

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Norton Pulmonary Specialists

    Louisville, Kentucky

  • Tufts Medical Center

    Boston, Massachusetts

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • NYU Langone Health

    New York, New York

  • New York Presbyterian Hospital - Weill Cornell Medicine

    New York, New York

  • University of Rochester Medical Center

    Rochester, New York

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • INTEGRIS Baptist Medical Center, Inc.

    Oklahoma City, Oklahoma

  • Houston Methodist Hospital

    Houston, Texas

  • University of Utah Health

    Salt Lake City, Utah

  • Royal Hobart Hospital

    Hobart, Tasmania, Australia

  • St. Vincent's Hospital Melbourne

    Fitzroy, Victoria, Australia

  • Všeobecná fakultní nemocnice v Praze

    Prague, Czechia

  • AP-HP Hôpital de Bicêtre

    Le Kremlin-Bicêtre, France

  • DRK Kliniken Berlin

    Berlin, Germany

  • Universitaetsklinikum Giessen und Marburg GmbH - Medizinische Klinik IV und V

    Giessen, Germany

  • Klinik für Pneumologie, Klinisches Studienzentrum Medizinische Hochschule

    Hanover, Germany

  • Thoraxklinik-Heidelberg gGmbH

    Heidelberg, Germany

  • Klinik und Poliklinik f. Innere Medizin II Universitätsklinikum Regensburg

    Regensburg, Germany

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

  • Hospital Universitario Marqués de Valdecilla

    Santander, Spain

  • Royal Papworth Hospital NHS Foundation Trust

    Cambridge, United Kingdom

  • Imperial College Healthcare NHS Trust - Hammersmith Medicines Research Limited

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.